Life sciences company Bio-Techne Corporation (NASDAQ: TECH) announced on Wednesday that its board of directors has approved a quarterly dividend of USD0.08 per share for Q3 2024.
This dividend is payable on 22 November 2024 to shareholders of record as of 11 November 2024.
The company said its board will continue to evaluate cash dividends on a quarterly basis.
Bio-Techne provides essential tools and reagents for research and clinical diagnostics, supporting drug discovery and accurate clinical testing. In fiscal 2024, the company reported USD1.2bn in net sales and employs approximately 3,100 people worldwide.
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland
Genomma Lab Internacional announces quarterly dividend
Abbott announces quarterly common dividend
West Pharmaceutical Services announces Q2 dividend
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
OptiBiotix expands into Indian market with Amazon launch
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share